Monday, April 25, 2016
Trovagene Names New CEO
San Diego-based molecular diagnostics developer Trovagene said today that it has named Bill Welch as its new CEO. Welch was most recently President and CEO of Sequenom, where he had been since January of 2011. Welch also served at Monogram Biosciences, La Jolla Pharmaceuticals, Dade Behring MicroScan, and Abbott Laboratories. Trovagene also said that Matthew Posard, the company's Chief Commercial Officer, has resigned and left the company; reason for the departure was not given.